Media-OutReach Newswire Abivax receives ANSM and Ethics Committee clearance to test its development candidate ABX464 in 1,034 Covid-19 patients in randomized Phase 2b/3 clinical trial
Media-OutReach Newswire DEUTZ AG: DEUTZ records growth in revenue and earnings in the first half of 2019 and confirms its full-year guidance